In this file
Whether TrimRx and MEDVi are the same company is an identity question before it is a purchasing comparison. Similar GLP-1 language does not reveal who owns a service, treats its patients, or fills its prescriptions. The relevant documents need to identify those roles explicitly.
Before deciding what to do, identify the exact plan or prescription involved. The answer below separates the provider’s documented position from details that still need confirmation. It also gives the next questions to ask and connects them to the relevant care, account, or payment issues.
Is TrimRx the same as MEDVi?
MEDVi and TrimRx operate distinct public services. We found no basis in these documents to treat them as one company or assume they assign the same clinicians and pharmacies. MEDVi’s page describes independent clinical services and names OpenLoop in its disclosures. Read its February 2026 FDA warning letter when evaluating the medication claims.
Identify each business role
A service agreement may name a platform operator, a consent may name a professional practice, and a dispensing label may name a pharmacy. Record what each entity does instead of assuming all three belong to the same business. A clinical-network name in a disclosure is useful evidence for that role, not automatic proof of ownership of the brand.
If the question comes from a transaction, begin with the legal name and contact route on the receipt. Ask the company to explain an unfamiliar descriptor. Similar logos, enrollment steps, ingredients, or support scripts do not establish a corporate relationship. A claim of shared ownership needs reliable records connecting the actual entities.
What changes if you move between the services?
An apparent similarity is not a reason to assume that records, prescriptions, or payments move automatically. The new clinical team may need an assessment and documentation even when the desired ingredient is unchanged. Ask which pharmacy will fill the new prescription and whether an old order remains active.
Resolve cancellation and any prepaid balance directly with the service that collected the payment. Keep confirmation of each action rather than treating a new enrollment as closure of the previous account. For clinical suitability, compare the proposed prescriptions with your clinician; for business identity, compare the legal documents. These inquiries can inform the same decision without answering one another.
Apply the answer to the actual TrimRx order
MEDVi’s disclosure naming OpenLoop describes a clinical arrangement. It does not establish that MEDVi and TrimRx have the same operator or owner. To investigate a relationship, request the legal entity responsible for each service and compare current business records for those exact names. To resolve an order problem, use the agreement and portal for the company that accepted the purchase. A similar medication or website should not be used to assume shared accounts, refunds, or records.
When a TrimRx policy depends on the selected plan, use the order number and name of the medication in your request. Ask for the action, effective date, amount, and any remaining task in one written response. That record is more useful than a general assurance that an account has been “handled.”
Medical instructions belong with the treating clinician or dispensing pharmacist. Subscription, privacy, and shipment requests may reach other teams. If one team redirects you, retain the original message and ask who now owns the request. Do not treat an administrative change as permission to change a prescription.
The principal TrimRx disclosures used here were captured September 21; attempts to refresh those pages on September 23 were blocked. Some company blog material remained accessible, but a blog should not be substituted for the current agreement on a specific purchase. Ask for the applicable terms and identify the proposed product before committing. If an answer in the signed-in account differs from this dated record, retain the newer document and ask the provider to explain the difference. The unresolved details are not evidence of either universal acceptance or universal refusal.
TrimRx vs. MEDVi: prescriptions, care, and costs
MEDVi and TrimRx operate distinct public services. We found no basis in these documents to treat them as one company or assume they assign the same clinicians and pharmacies. MEDVi’s page describes independent clinical services and names OpenLoop in its disclosures. Read its February 2026 FDA warning letter when evaluating the medication claims.
The complete TrimRx vs. MEDVi: prescriptions, care, and costs article explains that point and links its supporting records.
TrimRx vs. Ro: prescriptions, care, and costs
The meaningful TrimRx–Ro comparison starts with the proposed medicine and who bills for it. Ro’s current weight-loss material describes branded pathways; TrimRx’s dated disclosure separates its principal compounded program from outside-pharmacy branded prescriptions. A program price and the cost of an approved brand obtained through a pharmacy may cover different expenses.
The complete TrimRx vs. Ro: prescriptions, care, and costs article explains that point and links its supporting records.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- MEDVi - Personalized Telehealth Care ↗Provider-published information · Checked September 23, 2026
- FDA: MEDVi warning letter, February 20, 2026 ↗Regulatory / public agency · Checked September 22, 2026
- Weight Loss - Ro Body Membership | Ro ↗Provider-published information · Checked September 23, 2026
- Personalized Weight Loss Programs That Work | TrimRx ↗Provider-published information · Checked September 21, 2026
- BMI Calculator | BMI Chart for Women ↗Provider-published information · Checked September 23, 2026
- Terms and Conditions | Hims ↗Provider-published information · Checked September 23, 2026
- FAQ | Mochi Health ↗Provider-published information · Checked September 23, 2026
- MEDVi - Personalized Telehealth Care ↗Provider-published information · Checked September 23, 2026
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA ↗Regulatory / public agency · Checked September 23, 2026